DOP amends PTUAS, expands eligibility criteria to include MSMEs
Offers flexible financing options, and focuses on reimbursement subsidies from 10-20 per cent to MSMEs
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Schedule-M
FOPE request govt for funding to MSME to upgrade manufacturing facilities for revised Schedule M
The letter states that the said scheme may be similar to that which is for upgrading for WHO GMP
FOPE writes to govt raising concerns about new Schedule M amendment
The new Schedule M states that manufacturing premises must be exclusively used for the production of drugs, barring any other…
Decoding the skirmish over revised Schedule M
Both, large and mid/small size pharma companies, are vital parts of India’s pharma sector, one serving export markets, the other…
MoHFW announces revised Schedule M under the Drugs (Amendment) Rules, 2023
Small and medium manufacturers with an annual turnover of less than Rs 250 crore have 12 months to comply with the guidelines,…
Navigating the shift from low-cost to highest value
The Draft National Pharmaceuticals Policy 2023 advocates a shift from “exceptional quality at low cost” to “exceptional quality at…
India Pharma Inc in M&A mode once again
While the big names are in the news, we could see a similar consolidation among pharma MSMEs which might not hit the headlines
CDSCO to conduct awareness workshops on ‘Revision of Schedule M’
Held in association with IDMA, the offline workshops will be held at Bengaluru and Indore; Chennai and Dehradun this October
Telangana DCA issues approx 110 licenses for manufacturing hand sanitisers
Approves only those based on CDSCO-approved compositions